Occupational Health Clinics
Emerge Diagnostics is a California-based company focused on better management of musculoskeletal disorders (soft tissue injuries), with twin goals of better patient outcomes and reduced costs. With our years of experience applying electrodiagnostic medicine toward workplace injuries, Emerge leads the way with technological development and ongoing innovation.
Our technology enables a more accurate diagnosis allowing targeted, site-specific treatment recommendations that improve outcomes and return-to work times.
Our Mission at Emerge Diagnostics is providing better medical diagnostics with originality, ingenuity and innovation.
EFA Programs Provide
- Better targeted treatment solutions and quality of life
- Reduced lost time due to injuries
- Decreased frequency and severity of Soft tissue claims
Save the Date
See us at RIMSLIVE April 19-30, 2021
Shiraz Saeed National Practice Leader—Cyber Risk at Starr Insurance Companies and Mary Rose Cusimano-Reaston, Ph.D., Founder, CEO, President & CSO Emerge Diagnostics will be speaking at RIMS LIVE on Wednesday, April 21st at 4PM EST on the New Generation of Wearables & Developments in Legal Landscape Governing Biometric Information
RIMS LIVE 2021 is the most comprehensive risk management event the world has yet to experience – digitally. You’ll find insight, opportunity and connections to build a bigger, stronger and more versatile risk management community.
- 100+ hours of knowledge-building and thought-leading insight, available for 60 days.
- A game-changing digital RIMS Marketplace.
- Network-boosting social events for you to meet with other leaders in the profession.
- Greater diversity with risk professionals at all-levels from all parts of the world.
Soft tissue injuries are difficult to diagnose, and MRIs cannot help with sprain and strain injuries. Emerge’s Electrodiagnostic Functional Assessment (EFA) Test is designed to objectively diagnose and identify the location, extent, nature and age of soft tissue injuries. Our EFA technology is registered with the FDA as a Class II Medical Device for musculoskeletal disorders.
WHAT OUR CLIENTS ARE SAYING
Jack B. Weinstein
Senior Judge of the U.S. District Court for the Eastern District of New York
“This newly discovered evidence [the EFA Test] is unique and directly relevant to the crucial issue of causation. It is substantially probably that this medical report, created almost a year before the litigation was filed, would have caused the jury to evaluate all of the evidence at trial differently. The outcome at trial could well have been different if this evidence had been available.”
NOHS Occupational Medical Clinic, Tulsa, OK
“The Emerge program has allowed our clinic to provide a solution to diagnose soft muscle tissue injuries that has simply not existed before. Our physician now has a tool to identify a specific area injured and if needed, provide that information to a physical therapist who now knows exactly where to concentrate their efforts, thus providing a new level of care for our patients. This ability, combined with the Soft Tissue Management program to baseline employees, has definitely allowed our clients, the employer, to reduce loss time injuries, return employees to work much sooner, eliminate fraudulent claims and to therefore reduce workers compensation claims and overall costs.”
Lankford Construction finds Emerge Diagnostics’ Electrodiagnostic Functional Assessment (EFA) particularly effective in getting to the root of a worker’s injury. OSHA requires several criteria be met for a workman’s compensation claim to be required. Among these are death, loss of consciousness, treatment required beyond first aid, or as a result of a doctor or healthcare professional’s diagnosis. According to Tipps, many, if not most, soft-tissue claims don’t rise to meet these requirements.
Have an EFA System?
Emerge Technical Support:
Please fill out our contact form below, or call:
For training requests, please fill out our contact form below.
Directions to Emerge
Connect with Us
Connect with Emerge Diagnostics on LinkedIn for expert insights and our latest developments.